PharmaMar announces data presentations: Yondelis® and lurbinectedin at ASCO

0

(Pharmamar) During the Congress of the American Society of Clinical Oncology (ASCO) that will be held form the June 1-5 in Chicago (USA), PharmaMar will present the data obtained from various clinical studies of the molecules Yondelis ®, lurbinectedin (PM1183) and plitidepsin.

Leave a Reply

%d bloggers like this: